½ÃÀ庸°í¼­
»óǰÄÚµå
1594563

¾È±¸¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀå : À¯Çü, Á¦Ç°, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Ocular Adhesives & Sealants Market by Type (Natural, Synthetic), Product (Adhesives, Sealants), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 186 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾È±¸¿ë Á¢ÂøÁ¦¡¤½Ç¶õÆ® ½ÃÀåÀº 2023³â¿¡ 3¾ï 1,279¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 3¾ï 4,203¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.33%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 5¾ï 8,434¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾È°ú¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ®´Â ÁÖ·Î ¾È°ú ¼ö¼ú¿¡ »ç¿ëµÇ´Â Ư¼ö È­ÇÕ¹°·Î »óó ºÀÇÕÀ» ÃËÁøÇϰí Á¶Á÷ °áÇÕÀ» °­È­ÇÏ¸ç ¼ö¼ú ½Ã°£°ú ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇØ ÁÖ·Î ¾È°ú ¼ö¼ú¿¡ »ç¿ëµË´Ï´Ù. ¹é³»Àå ¼ö¼ú¿¡¼­ °¢¸· À̽Ä, ¸Á¸· ÀçÁ¢ÇÕ¼ú¿¡ À̸£±â±îÁö ´Ù¾çÇÑ ¿ëµµ·Î »ç¿ëµË´Ï´Ù. ÃÖÁ¾ »ç¿ë ¹üÀ§´Â ÁÖ·Î º´¿ø, Àü¹® ¾È°ú Ŭ¸®´Ð ¹× ¿¬±¸ ±â°üÀ» Æ÷ÇÔÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ¹ÙÀÌ¿À¼ÒÀçÀÇ ±â¼ú ¹ßÀü, °í·ÉÈ­¿¡ µû¸¥ ¾È°ú ¼ö¼ú Áõ°¡, ´ç´¢º´ °ü·Ã ¾È°ú ÇÕº´Áõ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä« µî Àα¸ °í·ÉÈ­¿Í ÀÇ·á ÀÎÇÁ¶ó°¡ ºü¸£°Ô Çö´ëÈ­µÇ°í ÀÖ´Â Áö¿ª¿¡¼­´Â ¼ºÀå ±âȸ°¡ ºÐ¸íÇÕ´Ï´Ù. ±â¾÷Àº ¾ö°ÝÇÑ »ýü ÀûÇÕ¼º ±âÁØÀ» ÃæÁ·ÇÏ´Â »ýºÐÇØ¼º Á¢ÂøÁ¦ ¹× õ¿¬ À¯·¡ Á¢ÂøÁ¦ °³¹ß¿¡ ÁýÁßÇÔÀ¸·Î½á À¯¸®ÇÑ À§Ä¡¸¦ È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¿¡µµ ºÒ±¸ÇÏ°í ³ôÀº R&D ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦, ´ëü »óó ºÀÇÕ¹ý°úÀÇ °æÀï µîÀÇ ¹®Á¦´Â ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» È®ÀÎÇϱâ À§ÇØ ´ë±Ô¸ð ÀÓ»ó½ÃÇèÀÌ ÇÊ¿äÇϸç, ½ÂÀαîÁö ¿À·£ ½Ã°£ÀÌ ¼Ò¿äµÇ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ȯÀÚÀÇ Æí¾ÈÇÔÀ» °³¼±Çϰí, ¼ö¼ú ÈÄ ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­Çϸç, ½ÀÇÑ È¯°æ¿¡¼­ Á¢ÂøÁ¦ÀÇ È¿´ÉÀ» Çâ»ó½Ã۱â À§ÇÑ ±â¼ú Çõ½ÅÀº ½ÃÀåÀ» Å©°Ô º¯È­½Ãų ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖ½À´Ï´Ù. Ãß°¡ ¿¬±¸¸¦ ÅëÇØ ÀÚ¿¬ Á¢Âø ¸ÞÄ¿´ÏÁòÀ» ¸ð¹æÇÑ »ýü À¯·¡ Á¢ÂøÁ¦¸¦ ޱ¸ÇÏ¿© »õ·Î¿î Çõ½ÅÀÇ ±æÀ» Á¦½ÃÇØ¾ß ÇÕ´Ï´Ù. ½ÃÀåÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ¼Ò¼öÀÇ ÁÖ¿ä ±â¾÷ÀÌ ¿ìÀ§¸¦ Á¡Çϰí ÀÖÁö¸¸, µ¿½Ã¿¡ ²÷ÀÓ¾øÀÌ ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ºü¸£°Ô ÀûÀÀÇϰí Çõ½ÅÇÒ ¼ö ÀÖ´Â ±â¾÷ÀÌ ¼º°øÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ±âÁ¸ ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷Àº ÀÓ»ó °Ë»ç¸¦ À§ÇÑ ÀÇ·á ±â°ü°úÀÇ Àü·«Àû Á¦ÈÞ¸¦ ¿ì¼±½ÃÇϰí, Á¦Ç° Ãâ½Ã¸¦ ¾Õ´ç±â±â À§ÇØ ±ÔÁ¦ Áöħ¿¡ ºÎÇÕÇϵµ·Ï ³ë·ÂÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023³â] 3¾ï 1,279¸¸ ´Þ·¯
¿¹Ãø³â[2024³â] 3¾ï 4,203¸¸ ´Þ·¯
¿¹Ãø³â[2030³â] 5¾ï 8,434¸¸ ´Þ·¯
CAGR(%) 9.33%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾È°ú¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

¾È°æ¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«ÀûÀÎ ÀÇ»ç°áÁ¤À» Á¤±³È­Çϸç, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ±âÁ¸ ºÀÇÕ¼úÀ» ´ëüÇÒ ¼ö ÀÖ´Â ¾È°ú¿ë Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
    • ¾ÈÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¾È°ú ¼ö¼ú¿¡ ´ëÇÑ ¼ÒºñÀÚ ÁöÃâ Áõ°¡
    • º¸Çè °¡ÀÔ °¡´É¼º Áõ°¡¿¡ µû¸¥ ¾È°ú ¼ö¼ú¿¡ ´ëÇÑ ³ôÀº ÀνÄ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ´«¿ë Á¢ÂøÁ¦ÀÇ ¼º´É ÇѰè
  • ½ÃÀå ±âȸ
    • ¹é³»Àå ¼ö¼ú¿¡ ´ëÇÑ Á¤ºÎÀÇ ±¸»ó°ú ÅõÀÚ
    • ´«¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ®ÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ¹ßÀü
  • ½ÃÀå °úÁ¦
    • ´«¿ë Á¢ÂøÁ¦ÀÇ Ç°Áú¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦

Porter's Five Forces: ´«¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» º¸¿ÏÇϸç ÀáÀçÀû µµÀüÀ» ÇÇÇÔÀ¸·Î½á º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾È°ú¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀå¿¡¼­ÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾È°ú¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾È°ú¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

´«¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© °ø±Þ¾÷ü°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: ¾È°ú¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀå¿¡¼­ÀÇ º¥´õ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾È°ú¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ: ¾È°ú¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀå¿¡¼­ ¼º°øÀ¸·Î °¡´Â ±æ Â÷Æ®

¾È°æ¿ë Á¢ÂøÁ¦ ¹× ½Ç¶õÆ® ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¾È±¸¿ë Á¢ÂøÁ¦¡¤½Ç¶õÆ® ½ÃÀå : À¯Çüº°

  • ¼­·Ð
  • õ¿¬
  • ÇÕ¼º

Á¦7Àå ¾È±¸¿ë Á¢ÂøÁ¦¡¤½Ç¶õÆ® ½ÃÀå : Á¦Ç°º°

  • ¼­·Ð
  • Á¢ÂøÁ¦
    • ½Ã¾Æ³ë¾ÆÅ©¸±·¹ÀÌÆ®°è ¾È°ú¿ë Á¢ÂøÁ¦
    • µ§µå¸®¸Ó°è Á¢ÂøÁ¦
    • Æä±× º£À̽º Á¢ÂøÁ¦
  • ½Ç¶õÆ®
    • ½Ã¾Æ³ë¾ÆÅ©¸±·¹ÀÌÆ®
    • ÇǺ기 Á¢ÂøÁ¦
    • ¸®½´¾î ½Ç¶õÆ®

Á¦8Àå ¾È±¸¿ë Á¢ÂøÁ¦¡¤½Ç¶õÆ® ½ÃÀå : ¿ëµµº°

  • ¼­·Ð
  • °á¸· ¼ö¼ú
  • °¢¸· ¼ö¼ú
  • ±¼Àý ±³Á¤ ¼ö¼ú
  • Á¶Á÷°øÇÐ
  • ÃÊÀÚü ¸Á¸· ¼ö¼ú

Á¦9Àå ¾È±¸¿ë Á¢ÂøÁ¦¡¤½Ç¶õÆ® ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • º´¿ø
  • ¾È°ú Ŭ¸®´Ð

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¾È±¸¿ë Á¢ÂøÁ¦¡¤½Ç¶õÆ® ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾È±¸¿ë Á¢ÂøÁ¦¡¤½Ç¶õÆ® ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¾È±¸¿ë Á¢ÂøÁ¦¡¤½Ç¶õÆ® ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

¾ð±ÞµÈ ±â¾÷

  • 3M Company
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton Dickinson & Company
  • Concord Drugs Ltd.
  • Connexicon Medical Limited
  • Corza Medical
  • Cryolife Inc.
  • CSL Behring LLC
  • Grena Ltd.
  • H.B. Fuller Company
  • Johnson & Johnson Services, Inc.
  • Ocular Therapeutix, Inc.
  • Reliance Life Sciences
  • Stryker Corporation
  • Surgitech Innovation
  • Vivostat A/S
KSA 24.11.29

The Ocular Adhesives & Sealants Market was valued at USD 312.79 million in 2023, expected to reach USD 342.03 million in 2024, and is projected to grow at a CAGR of 9.33%, to USD 584.34 million by 2030.

Ocular adhesives and sealants are specialized compounds used primarily in ophthalmic surgeries to facilitate wound closure, enhance tissue bonding, and reduce operative time and complications. Their necessity arises from the increasing prevalence of ocular disorders; their application spans from cataract surgeries to corneal transplantation and retinal reattachment procedures. The end-use scope predominantly includes hospitals, specialty eye clinics, and research institutes. Key growth drivers for the market include technological advancements in biomaterials, an increasing number of eye surgeries driven by an aging population, and the rising incidences of diabetes-related eye complications. There's a clear opportunity for growth in regions with aging demographics and where healthcare infrastructure is rapidly modernizing, such as Asia-Pacific and Latin America. Companies can position themselves advantageously by focusing on developing biodegradable and naturally-derived adhesives that meet stringent biocompatibility standards. Despite these opportunities, challenges like high R&D costs, stringent regulatory landscapes, and competition from alternative wound closure methods can limit market growth. Another significant limitation is the need for extensive clinical trials to ascertain safety and efficacy, often leading to lengthy approval processes. Innovations aimed at improving patient comfort, minimizing post-operative complications, and increasing adhesive efficacy in wet environments hold the potential for substantial market disruption. Further research should explore bio-inspired adhesives, which mimic natural adhesion mechanisms, presenting new avenues for innovation. The market is competitive, with a few key players dominating, yet it's also constantly evolving. Companies that can adapt quickly and innovate are more likely to thrive. To capitalize on existing opportunities, firms should prioritize strategic collaborations with medical institutions for clinical trials and ensure alignment with regulatory guidelines to expedite product launches.

KEY MARKET STATISTICS
Base Year [2023] USD 312.79 million
Estimated Year [2024] USD 342.03 million
Forecast Year [2030] USD 584.34 million
CAGR (%) 9.33%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ocular Adhesives & Sealants Market

The Ocular Adhesives & Sealants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for ocular products as an alternative to traditional suture procedures
    • Growing prevalence of ocular disorders with rising consumer expenditures on ocular surgeries
    • High awareness about ocular surgeries with increased insurance availability
  • Market Restraints
    • Performance limitations of ocular adhesives
  • Market Opportunities
    • Government initiatives and investments for cataract surgeries
    • Rapid advancements and developments in ocular adhesives & sealants
  • Market Challenges
    • Strict regulations regarding the quality of ocular adhesives

Porter's Five Forces: A Strategic Tool for Navigating the Ocular Adhesives & Sealants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ocular Adhesives & Sealants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ocular Adhesives & Sealants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ocular Adhesives & Sealants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ocular Adhesives & Sealants Market

A detailed market share analysis in the Ocular Adhesives & Sealants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ocular Adhesives & Sealants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ocular Adhesives & Sealants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ocular Adhesives & Sealants Market

A strategic analysis of the Ocular Adhesives & Sealants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ocular Adhesives & Sealants Market, highlighting leading vendors and their innovative profiles. These include 3M Company, B. Braun Melsungen AG, Baxter International, Inc., Becton Dickinson & Company, Concord Drugs Ltd., Connexicon Medical Limited, Corza Medical, Cryolife Inc., CSL Behring LLC, Grena Ltd., H.B. Fuller Company, Johnson & Johnson Services, Inc., Ocular Therapeutix, Inc., Reliance Life Sciences, Stryker Corporation, Surgitech Innovation, and Vivostat A/S.

Market Segmentation & Coverage

This research report categorizes the Ocular Adhesives & Sealants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Natural and Synthetic.
  • Based on Product, market is studied across Adhesives and Sealants. The Adhesives is further studied across Cyanoacrylate-Based Ocular Adhesives, Dendrimer-Based Adhesives, and Peg-Based Adhesives. The Sealants is further studied across Cyanoacrylate, Fibrin Glue, and Resure Sealant.
  • Based on Application, market is studied across Conjunctival Surgery, Corneal Surgery, Refractive Surgery, Tissue Engineering, and Vitreo-Retinal Surgery.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Ophthalmic Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for ocular products as an alternative to traditional suture procedures
      • 5.1.1.2. Growing prevalence of ocular disorders with rising consumer expenditures on ocular surgeries
      • 5.1.1.3. High awareness about ocular surgeries with increased insurance availability
    • 5.1.2. Restraints
      • 5.1.2.1. Performance limitations of ocular adhesives
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives and investments for cataract surgeries
      • 5.1.3.2. Rapid advancements and developments in ocular adhesives & sealants
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations regarding the quality of ocular adhesives
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ocular Adhesives & Sealants Market, by Type

  • 6.1. Introduction
  • 6.2. Natural
  • 6.3. Synthetic

7. Ocular Adhesives & Sealants Market, by Product

  • 7.1. Introduction
  • 7.2. Adhesives
    • 7.2.1. Cyanoacrylate-Based Ocular Adhesives
    • 7.2.2. Dendrimer-Based Adhesives
    • 7.2.3. Peg-Based Adhesives
  • 7.3. Sealants
    • 7.3.1. Cyanoacrylate
    • 7.3.2. Fibrin Glue
    • 7.3.3. Resure Sealant

8. Ocular Adhesives & Sealants Market, by Application

  • 8.1. Introduction
  • 8.2. Conjunctival Surgery
  • 8.3. Corneal Surgery
  • 8.4. Refractive Surgery
  • 8.5. Tissue Engineering
  • 8.6. Vitreo-Retinal Surgery

9. Ocular Adhesives & Sealants Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Ophthalmic Clinics

10. Americas Ocular Adhesives & Sealants Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Ocular Adhesives & Sealants Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Ocular Adhesives & Sealants Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Tissium Bags EURO 50 Million to Commercialize Tissue Repair Platform
    • 13.3.2. Team Develops Extracellular Matrix-Based Sticky Sealants For Corneal Tissue Reconstruction
    • 13.3.3. BD Acquires Surgical Sealant Films Developer Tissuemed
    • 13.3.4. Bio-Inspired, Blood-Repelling Tissue Glue Could Seal Wounds Quickly
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. B. Braun Melsungen AG
  • 3. Baxter International, Inc.
  • 4. Becton Dickinson & Company
  • 5. Concord Drugs Ltd.
  • 6. Connexicon Medical Limited
  • 7. Corza Medical
  • 8. Cryolife Inc.
  • 9. CSL Behring LLC
  • 10. Grena Ltd.
  • 11. H.B. Fuller Company
  • 12. Johnson & Johnson Services, Inc.
  • 13. Ocular Therapeutix, Inc.
  • 14. Reliance Life Sciences
  • 15. Stryker Corporation
  • 16. Surgitech Innovation
  • 17. Vivostat A/S
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦